Thursday, June 11, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 119 of 200 · By data quality, then INN

  1. carisbamate

    COMFYDE

    EMA: application withdrawn

  2. casirivimab

    RONAPREVE

    EMA: withdrawn

    J06BD07

  3. casopitant

    ZUNRISA

    EMA: application withdrawn

  4. caspofungin

    CANCIDAS (PREVIOUSLY CASPOFUNGIN MSD)

    EMA: approved · NMPA: clinical trials

    J02AX04

  5. catridecacog

    NOVOTHIRTEEN

    EMA: approved · PMDA: approved

    B02BD11

  6. catumaxomab

    KORJUNY

    EMA: approved

    L01FX03

  7. cediranib maleate

    ZEMFIRZA

    EMA: application withdrawn

    L01XE32

  8. cefepime

    EXBLIFEP

    EMA: approved

    J01DE51

  9. cefiderocol

    FETCROJA

    EMA: approved

    J01D

  10. ceftobiprole

    ZEFTERA (PREVIOUSLY ZEVTERA)

    EMA: refused

    J01DI01

  11. ceftolozane

    ZERBAXA

    EMA: approved

    J01DI54

  12. cenegermin

    OXERVATE

    EMA: approved

    S01

  13. cetrorelix

    CETROTIDE Merck KGaA, Darmstadt, Germany

    EMA: approved · TGA: approved

    H01CC02

  14. characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins

    CHONDROCELECT

    EMA: withdrawn

    M09AX02

  15. chenodeoxycholic acid

    CHENODEOXYCHOLIC ACID LEADIANT (PREVIOUSLY CHENODEOXYCHOLIC ACID SIGMA-TAU)

    EMA: approved

    A05AA01

  16. chikungunya vaccine (live)

    IXCHIQ

    EMA: approved

    J07BP01

  17. chikungunya vaccine (recombinant, adsorbed)

    VIMKUNYA

    EMA: approved

  18. chlormethine

    LEDAGA Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    L01AA05

  19. cholera vaccine (inactivated, oral)

    DUKORAL

    EMA: approved

    J07AE01

  20. cholera vaccine, oral, live

    VAXCHORA

    EMA: approved

    J07AE02

  21. ciclosporin

    APO-CICLOSPORIN Novartis Pharmaceuticals

    EMA: approved · TGA: approved

    S01XA18

  22. ciltacabtagene autoleucel

    CARVYKTI

    EMA: approved

    L01XL05

  23. cinacalcet

    CINACALCET VIATRIS Alphapharm Pty Ltd

    EMA: approved · TGA: approved · NMPA: clinical trials

    H05BX01

  24. cipaglucosidase alfa

    POMBILITI

    EMA: approved

    A16AB

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.